Gam Holding Ag Alkermes Plc. Transaction History

Gam Holding Ag

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$27.94 - $44.61 $1.98 Million - $3.16 Million	-70,902 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$38.6 - $46.12 $77 - $92	2 Added 0.0%	70,902 $3.01 Million
Q1 2018 May 15, 2018	SELL	$53.61 - $67.26 $1.45 Million - $1.82 Million	-27,000 Reduced 27.58%	70,900 $4.11 Million
Q4 2017 Feb 14, 2018	BUY	$47.69 - $55.39 $4.67 Million - $5.42 Million	97,900	97,900 $5.36 Million

350

183M

209K

89.4K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.76B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

Stay updated on Gam Holding Ag with notifications on news.